Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous sodium glutathione during primary PCI for acute myocardial infarction
2014-004486-25Phase 2Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Dec 2014
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of glutathione sodium in myocardial infarction (MI), sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Reduction of oxidative markers and inflammation after PCI. Started Dec 2014; status: active.
02
Drugs
glutathione sodium
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2014-004486-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004486-25.